|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
52528267
線上人數 :
1194
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"blauvelt a"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-10-22T07:27:58Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
|
Tha?i D.; Blauvelt A.; Reich K.; TSEN-FANG TSAI; Vanaclocha F.; Kingo K.; Ziv M.; Pinter A.; Hugot S.; You R.; Milutinovic M. |
| 臺大學術典藏 |
2020-10-22T07:27:55Z |
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
|
Fox T.; Papavassilis C.; Huang J.; Gong Y.; TSEN-FANG TSAI; Blauvelt A.; Leonardi C.L.; Griffiths C.E.M.; Reich K.; Van De Kerkhof P.C.M. |
| 臺大學術典藏 |
2020-10-22T07:27:53Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1?year: Results from the CLEAR study
|
Blauvelt A.; Reich K.; TSEN-FANG TSAI; Tyring S.; Vanaclocha F.; Kingo K.; Ziv M.; Pinter A.; Vender R.; Hugot S.; You R.; Milutinovic M.; Tha?i D. |
| 臺大學術典藏 |
2019 |
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study
|
Tha?I D.;Puig L.;Reich K.;Tsen-Fang Tsai;Tyring S.;Kingo K.;Ziv M.;Pinter A.;Vender R.;Lacombe A.;Xia S.;Bhosekar V.;Gilloteau I.;Guana A.;Blauvelt A.; Tha?i D.; Puig L.; Reich K.; TSEN-FANG TSAI; Tyring S.; Kingo K.; Ziv M.; Pinter A.; Vender R.; Lacombe A.; Xia S.; Bhosekar V.; Gilloteau I.; Guana A.; Blauvelt A. |
| 國立臺灣大學 |
2016 |
Secukinumab demonstrates an acceptable safety profile in moderate to severe plaque psoriasis: Pooled analysis of 10 phase 2/3 studies
|
Foley, P.; Griffiths, C.; Reich, K.; Leonardi, C. L.; Blauvelt, A.; Mehta, N. N.; Tsai, T. F.; Gong, Y.; Papavassilis, C.; Huang, J.; Fox, T.; van de Kerkhof, P.; 蔡呈芳 |
| 國立臺灣大學 |
2016 |
Secukinumab delivers greater improvement in health-related quality of life compared to ustekinumab in subjects with moderate to severe plaque psoriasis: 16-week data from the CLEAR study
|
Rubel, D.; Thaci, D.; Blauvelt, A.; Reich, K.; Tsai, T. F.; Vanaclocha, F.; Kingo, K.; Ziv, M.; Pinter, A.; Hugot, S.; You, R.; Augustin, M.; Milutinovic, M.; 蔡呈芳 |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
